Pfizer, J&J, Amgen and Roche Start a Bare-Knuckle Brawl Over Biosimilars

Pfizer, J&J, Amgen and Roche Start a Bare-Knuckle Brawl Over Biosimilars

Source: 
BioSpace
snippet: 

In August, Pfizer filed with the U.S. Food and Drug Administration (FDA) accusing Amgen and Roche of using social media to mislead doctors and patients about biosimilars and their effectiveness.